About Medrio
Medrio is a Healthcare company based in San Francisco (United States) founded in 2005. Cloud-based eClinical software for clinical trials is provided. Medrio has raised $32.03 million across 2 funding rounds from investors including Questa Capital and Ulu Ventures. The company has 120 employees. Medrio has completed 1 acquisition, including HMD clinical. Its chief executive, as recorded, is Nicole DuPont Latimer. Its website medrio.com draws about 133 thousand monthly visits. Medrio offers products and services including CDMS/EDC, eCOA/ePRO, eConsent, and RTSM. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include L7 Informatics, Clinical Research IO and VivoSense; 3 of its 3 listed competitors have raised funding.
Company details
Medrio was founded in 2005 in San Francisco, United States, and operates in the clinical trials sector. An integrated eClinical Software as a Service (SaaS) platform is offered, featuring a fully hosted Electronic Data Capture (EDC) system. Studies are enabled to be built entirely online without custom development requirements. Control is placed in the hands of study managers, by which study timelines and costs are reduced.
- Headquarters San Francisco, United States
- Employees 120
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website medrio.com
- Social LinkedIn X Facebook
- Legal Name Medrio
- Total Equity Funding$32.03M (USD)
in 2 rounds
- Latest Funding Round$30M (USD), Series B
May 2017
- InvestorsQuesta Capital
& 1 more
- Employee Count120
- Investments & Acquisitions
Products & Services of Medrio
Medrio offers a comprehensive portfolio of products and services, including CDMS/EDC, eCOA/ePRO, eConsent, and RTSM.
Platform for electronic data collection in clinical trials.
Tools for capturing clinical outcome assessments remotely.
System for electronic participant consent processes.
Software for trial supply randomization and control.
Funding Insights of Medrio
Medrio has successfully raised a total of $32.03M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.03M
- Total Rounds 2
- Last Round Series B — $30M
- First Round $2.03M
(Oct 2011)
- Investors Count 2
All 2 funding rounds of Medrio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | $30M | Series B | – | Questa Capital | – |
| Oct 2011 | $2.03M | Series A | – | Ulu Ventures | – |
2 investors in total: 2 institutional.
Investors in Medrio
Medrio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Questa Capital and Ulu Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage VC and PE investments are directed across multiple sectors. | questacapital.com | San Francisco, United States | ||
Seed-stage funding is provided to innovative founder teams. | uluventures.com | Palo Alto, United States |
Investor details for Medrio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medrio
58 people are tracked at Medrio (28 in leadership, 1 in board & advisors, 29 in team); the tracked headcount is 120.
| Name | Role | Group |
|---|---|---|
Nicole DuPont Latimer | CEO | Leadership |
Dan Lahaye | Director of Business Development | Leadership |
Camila Scullion | Marketing Director - Global & Emerging Markets | Leadership |
Mandana Varahrami | VP of Product | Leadership |
Jay Lomakin | Head Of Business Development, DTS | Leadership |
Jessica Guardado | Director Of Business Development | Leadership |
Chris Dixon | Human Resources Business Partner - People And Culture | Leadership |
Ed Gould | Chief Financial Officer | Leadership |
Muhammad Bilal | VP Clinical Data Services | Leadership |
Julie Tyson | Sr. Director, Clinical Data Services At Medrio | Leadership |
Mike Lewis (He/Him) | Chief Revenue Officer | Leadership |
Andrew Ferrin | Vice President, Direct to Sponsor Sales | Leadership |
Neil McClenney | Senior Vice President, Chief Compliance Officer | Leadership |
Laurin Willetts | Strategic Partner | Leadership |
Jason Hill | Director of Software Engineering | Leadership |
Jeff Johnson | Sr. Director Support Services | Leadership |
Gabriel Westerlund | Director of Revenue Operations | Leadership |
Rochelle Shearlds, MBA (She/Her) | Vp, Sales And Account Management | Leadership |
Molly Dhir | Senior Director of Business Development | Leadership |
Alana Rostock Wirt | Director of Business Development | Leadership |
38 more people are available in the full profile.
Complete people profiles for Medrio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medrio
Medrio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HMD clinical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical Trial Management System | hmdclinical.com | Edinburgh, United Kingdom | 2002 | Apr 2021 | •••• |
Complete acquisition details for Medrio
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medrio
4 dated milestones of Medrio across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Medrio is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series B, of $30.0M.
- Acquisition Acquires HMD clinical.
Competitors of Medrio
Medrio has 3 listed competitors in our database, 3 of them funded. They include L7 Informatics, Clinical Research IO and VivoSense.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| l7informatics.com | 2012 | Austin, United States | $54.97M | 126 | Clinical trial workflow management software is provided for laboratories. | |
| clinicalresearch.io | 2015 | Boston, United States | $16.7M | 16 | Clinical trial management software is provided for research sites. | |
| vivosense.com | 2010 | San Diego, United States | $27.46M | Wearable sensor research analysis platform |
Detailed competitors of Medrio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Medrio
The website of Medrio (medrio.com) receives about 133.1K visits a month and ranks #199,158 among all websites worldwide, #126 in Biotechnology and Pharmaceuticals.
- Monthly visits133.1K
▲ 15.3% vs previous month
- Unique visitors32.7K
per month
- Global rank#199,158
among all websites
- Category rank#126
Health · Biotechnology and Pharmaceuticals
- Bounce rate31%
- Pages per visit10.8
- Average visit5 min 13 sec
- DevicesDesktop 46% · Mobile 54%
Websites whose visitors overlap most with Medrio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| suvoda.com | 100% | 100.2K | #299,441 | View details | |
| fortressmedical.com | 99% | View details | |||
| advarra.com | 99% | 102.4K | #325,515 | View details | |
| florencehc.com | 98% | 28.6K | #961,319 | View details | |
| iqvia.com | 97% | 1.2M | #45,953 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Medrio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Medrio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medrio
Complete news archive for Medrio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medrio
Medrio was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Medrio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nicole DuPont Latimer is the CEO of Medrio, as recorded in our data.
Medrio is a funded company, having raised a total of $32.03M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.03M, raised on Oct 2011.
Medrio has 120 employees.
Medrio was founded in 2005 in San Francisco, United States, and operates in the clinical trials sector. An integrated eClinical Software as a Service (SaaS) platform is offered, featuring a fully hosted Electronic Data Capture (EDC) system. Studies are enabled to be built entirely online without custom development requirements. Control is placed in the hands of study managers, by which study timelines and costs are reduced.
Medrio's top competitors include L7 Informatics, Clinical Research IO and VivoSense.
Medrio offers CDMS/EDC, eCOA/ePRO, eConsent, and RTSM.
Medrio has made 1 acquisition, including HMD clinical.
Medrio has 2 investors. Key investors include Questa Capital, and Ulu Ventures.
Medrio operates through Medrio.
The website of Medrio receives about 133 thousand visits a month and ranks #199,158 among all websites worldwide.